Akebia Therapeutics Inc. (AKBA) jumped 6.1% or 0.6 to $10.43. It is close to 358043 shares traded, which is 79.71% compare to the average total volume 449169. The market cap of AKBA is $593.29 million. The year to date change is -34.34%. The 52 week price range is from $8.93 to $20.25. Price of AKBA have changed 0.82% during last week. It have changed 0.61% over last month, -32.07% over last 3 months, -34.77% over last 6 months and -23.80% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKBA is 10.64. It is 2.01% above current price. The 200-day Moving Averages for AKBA is 14.57. It is 39.69% above current price. The 52-week High is 20.25. It is 94.15% from the current price. The 52-week Low is 8.93. It is -14.38% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of AKBA is 6.3 on 2018-04-30. Short % to float is 5.56%. There are some statistics of AKBA. It is has market cap $593.29 million. The share outstanding is 56.88 million. The average volume is 449169. The revenue is 69.80M. The percent of top 15 Institution holding is 65.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKBA is -78.07%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKBA is -21.77%.